Bank Of New York Mellon Corp Intercept Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$12.53 - $21.71 $2.2 Million - $3.82 Million	175,781 New	175,781 $2.36 Billion
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $2.26 Million - $3.13 Million	194,283 New	194,283 $2.4 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $83,723 - $135,082	6,857 Added 6.98%	105,164 $1.47 Million
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $83,349 - $145,396	-7,422 Reduced 7.02%	98,307 $1.36 Million
Q1 2022 May 11, 2022	BUY	$13.37 - $17.79 $35,350 - $47,036	2,644 Added 2.56%	105,729 $1.72 Million
Q4 2021 Feb 11, 2022	BUY	$14.28 - $19.53 $140,843 - $192,624	9,863 Added 10.58%	103,085 $1.68 Million
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $165,271 - $260,439	12,723 Added 15.81%	93,222 $1.38 Million
Q2 2021 Aug 11, 2021	SELL	$15.46 - $24.5 $343,072 - $543,679	-22,191 Reduced 21.61%	80,499 $1.61 Million
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $45,309 - $88,486	-2,344 Reduced 2.23%	102,690 $2.37 Million
Q4 2020 Feb 09, 2021	SELL	$24.48 - $42.47 $14,320 - $24,844	-585 Reduced 0.55%	105,034 $2.59 Million
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $193,143 - $264,047	-4,941 Reduced 4.47%	105,619 $4.38 Million
Q2 2020 Aug 12, 2020	BUY	$46.7 - $92.04 $182,316 - $359,324	3,904 Added 3.66%	110,560 $5.3 Million
Q1 2020 May 06, 2020	SELL	$48.35 - $118.68 $379,015 - $930,332	-7,839 Reduced 6.85%	106,656 $6.72 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $885,925 - $1.92 Million	15,445 Added 15.59%	114,495 $14.2 Million
Q3 2019 Nov 07, 2019	SELL	$58.69 - $80.46 $71,190 - $97,597	-1,213 Reduced 1.21%	99,050 $6.57 Million
Q2 2019 Aug 12, 2019	BUY	$77.77 - $120.68 $366,063 - $568,040	4,707 Added 4.93%	100,263 $7.98 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $104,410 - $137,213	1,137 Added 1.2%	95,556 $10.7 Million
Q4 2018 Feb 11, 2019	BUY	$85.79 - $126.46 $102,261 - $150,740	1,192 Added 1.28%	94,419 $9.52 Million
Q3 2018 Nov 09, 2018	BUY	$88.49 - $127.55 $295,733 - $426,272	3,342 Added 3.72%	93,227 $0
Q2 2018 Aug 06, 2018	BUY	$60.0 - $85.67 $1.1 Million - $1.57 Million	18,340 Added 25.63%	89,885 $7.54 Million
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $169,547 - $216,276	-3,216 Reduced 4.3%	71,545 $4.4 Million
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $4.35 Million - $5.44 Million	74,761	74,761 $4.37 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account